SCHEMBL6310651

SCHEMBL6310651

Cc1nc(C#Cc2ccccc2)sc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 15/20 0.54
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PKM P14618 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
CYP2C19 P33261 1/20 0.44
THPO P40225 1/20 0.44
KMT2A Q03164 1/20 0.44
GRIN2B Q13224 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17066356 0.85 GRM5 (0.46) GRM5ALDH1A1GAARAB9AKDM4E
SCHEMBL1658046 0.78 SMN1; SMN2 (0.54) GRM5ALDH1A1GAANPC1RAB9A
SCHEMBL17059010 0.76 GRM5 (0.49) GRM5ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1663331 0.74 GRM5 (0.48) GRM5
SCHEMBL1657564 0.72 NPC1 (0.60) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL6312837 0.70 GRM5 (0.50) GRM5ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL27890456 0.70 NPC1 (0.47) GRM5ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6869139 0.70 ALDH1A1 (0.44) ALDH1A1GAANPC1RAB9ASMN1; SMN2
SCHEMBL19135631 0.68 GRM5 (0.44) GRM5ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL17341754 0.68 APP (0.46) GRM5ALDH1A1GAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956049-B1 Methods of modulating processes mediated by excitatory amino acid receptors MERCK & CO., INC. (US) 2005-10-18 US disclosed
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed